Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients

Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients

Breast cancer-related lymphedema (BCRL) occurs in ~ 40% of patients after axillary lymph node dissection (ALND), radiation therapy (RT), or chemotherapy. First-line palliative treatment utilizes compression garments and specialized massage. Reparative microsurgeries have emerged as a second-line tre...

Full description

Bibliographic Details
Main Authors: Anna R. Vang, Simona F. Shaitelman, John C. Rasmussen, Wenyaw Chan, Eva M. Sevick-Muraca, Melissa B. Aldrich
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
lymphedema
breast cancer
cytokine/chemokine
biomarkers
dermal backflow
NIRF-LI
Online Access:https://www.mdpi.com/2072-6694/15/3/676

Internet

https://www.mdpi.com/2072-6694/15/3/676

Similar Items